Danone Sells Horizon Organic, Wallaby U.S. Businesses to Platinum Equity
By Adria Calatayud
Danone said it would sell its Horizon Organic and Wallaby organic-dairy businesses in the U.S. to investment firm Platinum Equity for an undisclosed sum.
The French producer of yoghurts, bottled water and infant-nutrition products said Tuesday that the sale agreement is part of a portfolio review launched in 2022. The brands represented about 3% of the group's global revenue and had a dilutive impact on its like-for-like sales growth and recurring operating margin, Danone said.
"This sale, once completed, will allow us to concentrate further on our current portfolio of strong, health-focused brands and reinvest in our growth priorities," Danone Chief Executive Antoine de Saint-Affrique said.
Platinum Equity separately said the brands will benefit from its carve-out experience and operational expertise. Its portfolio includes cookie maker Biscuit International, wine producer Fantini Group Vini and seafood provider Iberconsa.
Danone said it would retain a minority stake that won't be consolidated into its results after completing the sale, which remains subject to customary conditions.
Write to Adria Calatayud at adria.calatayud@dowjones.com
(END) Dow Jones Newswires
January 02, 2024 01:25 ET (06:25 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom